For healthcare marketers, obesity care is evolving beyond a niche therapeutic category into a major healthcare ecosystem involving pharmaceuticals, digital health, metabolic care, nutrition services, employer health programs, and chronic disease management
First, it's important to note that data from human clinical trials involving ipamorelin is extremely limited
Financial support and sponsorship This work is funded by the 2024 National Clinical Key Specialty Construction Program of China (Department of Endocrinology, Peking University Peoples Hospital) with support from the central government budget
BMC Genet
Furthermore, studies reveal that KYN pathway metabolites, particularly quinolinic acid (QA), are significantly elevated in CKD patients due to altered tryptophan metabolism by gut microbiota
A centenary of gastrointestinal endocrinology